Question 1

What is the share price of GlaxoSmithKline Pharmaceuticals Limited today?

Accepted Answer

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is trading at ₹2,515.1. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is GLAXO’s P/E ratio versus the sector?

Accepted Answer

GLAXO trades at a P/E of 41.1. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is GLAXO’s dividend yield?

Accepted Answer

GLAXO has a dividend yield of 2.22%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is GLAXO’s 52-week high and low?

Accepted Answer

GLAXO has traded between ₹2,088.1 and ₹3,120.7 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of GlaxoSmithKline Pharmaceuticals Limited?

Accepted Answer

GlaxoSmithKline Pharmaceuticals Limited has a market capitalisation of ₹43,471 crore.

Question 6

What is GLAXO’s return on equity?

Accepted Answer

GLAXO reports a return on equity of 43.3%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - General.

Question 7

Who are GLAXO’s competitors?

Accepted Answer

The Peers block on this page lists other Drug Manufacturers - General companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is GLAXO’s promoter holding?

Accepted Answer

Promoters hold 75.00% of GLAXO. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include GLAXO?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight GLAXO carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is GlaxoSmithKline Pharmaceuticals Limited a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from GLAXO’s own numbers. The judgement is yours.

Revenue	₹3,790 crore
Net profit	₹1,012 crore
Operating margin	34%
EPS	₹59.73

GLAXO

GLAXO

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

GLAXO financial summary